Exploring MFN Policy Effectiveness in Drug Pric...

By João L. Carapinha

February 19, 2026

MFN Policy Effectiveness in Countering Freeloading Claims The MFN policy effectiveness is evident in the coalition letter dated February 12, 2026, which opposes codifying Mos...
Zorginstituut Nederland’s Lecanemab Health Insurance Rejection: Implica...
Glofitamab Cost-Effectiveness: Conditional Reimbursement Insights for DLBCL T...
NICE Endorses Pegzilarginase for Treating Arginase Deficiency
Transformative PBM Reform Legislation Signed into Law
Pharmaceutical Tender Investigation Sparks Regulatory Scrutiny in South Africa
South Africa Health Reform: Navigating Innovations and Challenges for 2026
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
Novartis Drug Pricing Agreement
Strategic Avalere Health Appointments Enhance Leadership in Navigating US Hea...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...